Schrödinger, Inc. strongly supports the U.S. Food and Drug Administration's (FDA) plan to reduce, refine or potentially replace current animal testing requirements with new approaches designed to ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

AMSBIO is helping to advance glycobiology research by supplying a trusted portfolio of high-affinity Heparan Sulfate (HS) monoclonal antibodies, now widely used in leading research laboratories ...

• There is not enough evidence to determine the best method for preventing haemolytic uraemic syndrome (HUS) in patients with Shiga toxin-producing Escherichia coli (STEC)-associated diarrhoea. • More ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

PETA and other animal advocacy groups have praised the Trump administration for recent announcements to phase out animal ...

A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

Right now, Hartung says scientists can use AI to pull and analyze millions of scientific papers as a way of screening chemical substances for potential problems instead of subjecting zebrafish and ...